CROs, clinical researchers brace for impact of coronavirus shutdown across China

In recent years, China has become a key region for clinical trial research sites, but the ongoing quarantine and partial travel lockdown to and from the country is putting a strain on research.

With more than 1,000 deaths and tens of thousands of people infected with the COVID-19 coronavirus in China, the country’s government is continuing its tough crackdown on freedom of movement in an attempt to stop the virus from further spread.